The Global Market for Molecular Cytogenetics is Projected to Reach US$2.3 Billion by 2022

Unmet Diagnostic Needs in Cancer & Genetic Disorders to Drive the Molecular Cytogenetics Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Molecular Cytogenetics market. The global market for Molecular Cytogenetics is projected to reach US$2.3 billion by 2022, driven by the rising demand for rapid and accurate diagnostic techniques which involve detection of chromosomal anomalies that predispose patient groups to various diseases.

Molecular Cytogenetics refers to extensive studies of chromosomal variation and abnormalities, and their relation to disease. Cytogenetics plays an important role in identification of genetic predisposition to disease and also a person’s reaction to a certain drug.  Simpler cytogenetic technologies, such as Capillary Electrophoresis (CE), first generation amplification, and PCR (Polymerase Chain Reaction) have given way to advancements such as Fluorescence in Situ Hybridization (FISH) as well as array-based technologies, in particular array-based Comparative Genome Hybridization (aCGH). Advanced molecular cytogenetic technologies have assumed an extremely significant role in medical research. aCGH as a high-resolution tool that offers the unique ability of performing thousands of experiments in one array is fast replacing FISH technology, with advantages in terms of rapid and accurate diagnosis.

Cytogenetic techniques aid pathologists in diagnosis and prognosis related to solid tumors and hematological malignancies. With the increasing incidence of cancer worldwide, the scope of molecular cytogenetics is increasing. Better understanding of the relation between certain chromosomal anomalies and cancers has necessitated their detection through multiplex or multicolor Fluorescence In Situ Hybridization (multiplex FISH). Whole-genome tools, such as microarrays and next-generation sequencing (NGS), enable the study of the whole genome from a few malignant cells, at a resolution and precision high enough to detect abnormalities and consider potential rearrangements. Apart from improving quality of care and treatment, molecular cytogenetics also assist physicians in developing personalized therapies by leveraging the concepts of pharmacogenomics and pharmacogenetics. Demand for higher-resolution chromosomal analysis stands to benefit from research studies linking chromosomal abnormality to autism, schizophrenia, as well as cancer.

As stated by the new market research report on Molecular Cytogenetics, the United States represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of 27.4% over the analysis period. The growth in the region is led by growing population, high disease prevalence, unmet needs in effective disease diagnosis, rise in chromosome abnormalities due to unchecked and uncontrolled pollution in emerging economies, and growing per capita healthcare spending in developing countries like China and India.   

Major players covered in the report include Abbott Molecular Inc., Agilent Technologies Inc., Affymetrix Inc., Applied Spectral Imaging, Biological Industries, Bio-Rad Laboratories Inc., CytoTest Inc., Cytognomix Inc., Illumina Inc., Leica Biosystems Nussloch GmbH, Oxford Gene Technology, PerkinElmer Inc., Roche NimbleGen Inc., SciGene Corporation, and Thermo Fisher Scientific, Inc.

The research report titled "Molecular Cytogenetics: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers, mergers and acquisitions, and other strategic industry activities of major companies worldwide. The report provides market estimates and projections for geographic markets, such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China and Rest of Asia-Pacific) and Rest of World. Technology segments analyzed for the market include FISH (Fluorescent In Situ Hybridization) and Array-based Technologies.  

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.